Unexpected discovery of hemoglobinopathy C/β° thalassemia

Abstract

Key Clinical MessageHigh performance liquid chromatography (HPLC) is the current method of choice for the detection of hemoglobinopathies and the quantification of A2 and fetal hemoglobin. We are describing a case where a double heterozygosity C/beta‐thalassemia was fortuitously identified, during assaying HBA1c, by HPLC.